Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis: A shared phenotype across brain‐expressed sodium channelopathies
Open Access
Abstract
Objective: Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis (NDEEMA) represents the most severe end of the gain‐of‐function (GOF) SCN1A disorder spectrum. Sporadic cases of congenital arthrogryposis have also been reported in individuals with SCN2A‐ , SCN3A‐, and SCN8A ‐related developmental and epileptic encephalopathy. Here, we investigated whether NDEEMA occurs in other brain‐expressed sodium channelopathies and characterized its features. Methods: Individuals with the clinical phenotype of NDEEMA were identified through internal databases, an international network of epileptologists and geneticists, and the literature. Their clinical and genetic information was analyzed. A literature survey was conducted to review studies describing the functional effects of the pathogenic variants. Results: Of 46 NDEEMA individuals, 25 harbored variants in SCN1A , 13 in SCN2A , one in SCN3A, and seven in SCN8A . Thirty‐five different pathogenic/likely pathogenic missense variants were identified, all of which clustered in evolutionary conserved paralogous Na V positions. Five individuals died in utero. Thirty‐nine of 41 (95%) liveborn individuals developed neonatal epilepsy with tonic seizures and/or apnea. Thirty‐one individuals tried sodium channel blockers, of whom 21 (68%) experienced seizure reduction. All individuals for whom information was available developed movement disorders, with myoclonus, dystonia, and tremor being the most common features. Literature review of functional studies revealed that nine NDEEMA variants, and the corresponding paralogues of 16 additional NDEEMA variants, have been biophysically characterized as GOF. Significance: This study expands the phenotype of NDEEMA from SCN1A to its paralogue sodium channel genes expressed in the brain: SCN2A, SCN3A , and SCN8A .Keywords
This publication has 49 references indexed in Scilit:
- Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic SpectrumAnnals of Clinical and Translational Neurology, 2025
- Clinical and electrophysiological features of SCN8A variants causing episodic or chronic ataxiaEBioMedicine, 2023
- Skeletal anomaly and opisthotonus in early-onset epileptic encephalopathy with KCNQ2 abnormalityBrain and Development, 2023
- SCN3A‐Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain MalformationAnnals of Neurology, 2020
- Differential excitatory vs inhibitory SCN expression at single cell level regulates brain sodium channel function in neurodevelopmental disordersEuropean Journal of Paediatric Neurology, 2020
- Biallelic loss of function variants in ATP1A2 cause hydrops fetalis, microcephaly, arthrogryposis and extensive cortical malformationsEuropean Journal of Medical Genetics, 2020
- Central nervous system involvement in arthrogryposis multiplex congenita: Overview of causes, diagnosis, and careAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2019
- Clinical and genetic spectrum of SCN2A-associated episodic ataxiaEuropean Journal of Paediatric Neurology, 2019
- De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and DyskinesiasThe American Journal of Human Genetics, 2018
- Arthrogryposis (multiple congenital contractures): Diagnostic approach to etiology, classification, genetics, and general principlesEuropean Journal of Medical Genetics, 2014